These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 11593415

  • 21. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.
    Voelkel-Johnson C, King DL, Norris JS.
    Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034
    [Abstract] [Full Text] [Related]

  • 22. Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells.
    Kulik G, Carson JP, Vomastek T, Overman K, Gooch BD, Srinivasula S, Alnemri E, Nunez G, Weber MJ.
    Cancer Res; 2001 Mar 15; 61(6):2713-9. PubMed ID: 11289152
    [Abstract] [Full Text] [Related]

  • 23. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK.
    Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926
    [Abstract] [Full Text] [Related]

  • 24. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation.
    Cho YL, Lee KS, Lee SJ, Namkoong S, Kim YM, Lee H, Ha KS, Han JA, Kwon YG, Kim YM.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):752-8. PubMed ID: 15607733
    [Abstract] [Full Text] [Related]

  • 25. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
    Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA.
    Cell Death Differ; 2003 Jun 28; 10(6):729-39. PubMed ID: 12761581
    [Abstract] [Full Text] [Related]

  • 26. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN.
    Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279
    [Abstract] [Full Text] [Related]

  • 27. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA, Chen MK, Iyengar M, Dai W, Nagaram A, Beierle EA.
    J Pediatr Surg; 2006 Jun 15; 41(6):1072-80. PubMed ID: 16769337
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
    Imose M, Nagaki M, Naiki T, Osawa Y, Brenner DA, Asano T, Hayashi H, Kato T, Moriwaki H.
    Liver Int; 2003 Oct 15; 23(5):386-96. PubMed ID: 14708901
    [Abstract] [Full Text] [Related]

  • 29. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y, Eid MA, Lewis RW, Kumar MV.
    Cell Signal; 2005 Feb 15; 17(2):243-51. PubMed ID: 15494215
    [Abstract] [Full Text] [Related]

  • 30. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB.
    Cancer Res; 2002 Jan 15; 62(2):488-96. PubMed ID: 11809700
    [Abstract] [Full Text] [Related]

  • 31. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP, Zisman A, Bonavida B.
    Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140
    [Abstract] [Full Text] [Related]

  • 32. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
    Aggarwal BB, Bhardwaj U, Takada Y.
    Vitam Horm; 2004 Dec 01; 67():453-83. PubMed ID: 15110190
    [Abstract] [Full Text] [Related]

  • 33. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 34. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
    Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS.
    J Biol Chem; 2003 Jul 11; 278(28):25872-8. PubMed ID: 12738789
    [Abstract] [Full Text] [Related]

  • 35. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
    Hu H, Jiang C, Li G, Lü J.
    Carcinogenesis; 2005 Aug 11; 26(8):1374-81. PubMed ID: 15845651
    [Abstract] [Full Text] [Related]

  • 36. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N, El-Deiry WS.
    Neoplasia; 2002 Aug 11; 4(6):551-7. PubMed ID: 12407450
    [Abstract] [Full Text] [Related]

  • 37. Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway.
    Lee YJ, Song JJ, Kim JH, Kim HR, Song YK.
    Exp Cell Res; 2004 Feb 01; 293(1):129-43. PubMed ID: 14729063
    [Abstract] [Full Text] [Related]

  • 38. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 39. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
    Panka DJ, Mano T, Suhara T, Walsh K, Mier JW.
    J Biol Chem; 2001 Mar 09; 276(10):6893-6. PubMed ID: 11145953
    [Abstract] [Full Text] [Related]

  • 40. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.